.
3/13/14, "New York hospital warns patients of possible HIV, hepatitis exposure," Reuters
"A New York
hospital on Wednesday alerted more than 4,200 patients who may have
received insulin of possible exposure to hepatitis viruses and human
immunodeficiency virus (HIV) due to possible blood contamination,
officials and local media said.
South Nassau
Communities Hospital in Oceanside on Long Island, near New York City,
said patients may have received insulin from a pen reservoir - not a
single-use disposable needle - that could have been used on more than
one patient.
"The risk of
infection from this is extremely low," the hospital said in a statement,
adding it was recommending patients "be tested for hepatitis B,
hepatitis C and HIV."
When asked if anyone was confirmed to have been infected a hospital spokeswoman said "not to my knowledge."
The
pen-shaped insulin injector devices are often used by hospitals to give
the hormone to patients and contain a reservoir or cartridge, the
Centers for Disease Control and Prevention say.
The
pens should be limited to one patient because regurgitation of blood
into the insulin cartridge can occur after injection, creating a risk of
blood-borne pathogen transmission, even when the needle is changed,
according to the CDC.
Some 200 of the more than 4,000 patients who were warned have signed up for free blood testing, WABC-TV reported.
The hospital seems to have changed its policy on the devices, though it was unclear when the change occurred.
"South
Nassau has already implemented a hospital-wide policy that bans the use
of insulin pens and permits only the use of single-patient-use vials to
administer prescribed insulin treatments to patients," the statement
said.
HIV can lead to AIDS, or the acquired
immunodeficiency syndrome, and hepatitis refers to a group of viral
infections that affect the liver, according to the CDC."
.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment